Glymphatic dysfunction evidenced by DTI-ALPS is related to obstructive sleep apnea intensity in newly diagnosed Parkinson’s disease
The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
Clinical and functional evidence for the pathogenicity of the LRRK2 p.Arg1067Gln variant
Alpha-Synuclein Conformations in Plasma Distinguish Parkinson’s Disease from Dementia with Lewy Bodies
Novel Co-culture Model of T Cells and Midbrain Organoids for Investigating Neurodegeneration in Parkinson's Disease
The Association Between Real Life-Assessed Sit-to-Stand and Stand-to-Sit Kinematics with Self-Reported Levels of Physical and Mental Fatigue in Neurodegenerative and Immune-Mediated Inflammatory Diseases
The diagnostic pathway of Parkinson’s disease: understanding patient perspectives in Australia
Systematic review of wearables assessing medication effect on motor function and symptoms in Parkinson’s disease
Mapping the distribution of neurotransmitters to resting-state functional connectivity in patients with Parkinson’s disease
CSF Sphingolipids in Parkinson Disease and Dementia with Lewy Bodies with and without GBA1 variants